BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2971490)

  • 1. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
    Cowan MJ; Shannon KM; Wara DW; Ammann AJ
    Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Silber GM; Winkelstein JA; Moen RC; Horowitz SD; Trigg M; Hong R
    Clin Immunol Immunopathol; 1987 Sep; 44(3):317-20. PubMed ID: 3304740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency.
    Cowan MJ; Smith W; Ammann AJ
    Clin Immunol Immunopathol; 1989 Oct; 53(1):59-67. PubMed ID: 2569954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine metabolism in adenosine deaminase deficiency.
    Simmonds HA; Sahota A; Potter CF; Perrett D; Hugh-Jones K; Watson JG
    Ciba Found Symp; 1978; (68):255-62. PubMed ID: 387357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological reconstitution after HLA-haploidentical bone marrow transplantation for SCID in an infant with ADA deficiency.
    Lanfranchi A; Nespoli L; Porta F; Martelli MF; Aversa F; Bonetti F; Locatelli F; Gibardi A; Martinetti M; Burgio GR
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():168-70. PubMed ID: 2627620
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
    Barton RW
    Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
    Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
    Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
    Schmalstieg FC; Mills GC; Tsuda H; Goldman AS
    Pediatr Res; 1983 Dec; 17(12):935-40. PubMed ID: 6606796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
    Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
    J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.
    Hirschhorn R; Roegner-Maniscalco V; Kuritsky L; Rosen FS
    J Clin Invest; 1981 Dec; 68(6):1387-93. PubMed ID: 7033281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
    Polmar SH
    Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
    Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
    J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA
    Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-haploidentical bone marrow transplantation in three infants with adenosine deaminase deficiency: stable immunological reconstitution and reversal of skeletal abnormalities.
    Bluetters-Sawatzki R; Friedrich W; Ebell W; Vetter U; Stoess H; Goldmann SF; Kleihauer E
    Eur J Pediatr; 1989 Nov; 149(2):104-9. PubMed ID: 2591400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.
    Hirschhorn R; Roegner V; Rubinstein A; Papageorgiou P
    J Clin Invest; 1980 Mar; 65(3):768-71. PubMed ID: 6965496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
    Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
    Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.